Tag Archives: Michael J. Pellini

Roche to acquire up to 56.3% interest in Foundation Medicine, Inc. on a fully diluted basis through a tender and acquisition of newly issued shares

BASEL, 12-1-2015 — /EuropaWire/ — Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer Roche to acquire a majority interest in Foundation Medicine (FMI) of up to 56.3% on a fully diluted basis … Read the full press release